Patriot News Organization

A new study offers an alternative for older adults who are unable to commit to a regular exercise regimen. According to the international research team, a few minutes of energetic everyday movements may reduce the risk of early death. The…

Thanks to advances in cancer therapies, most forms of breast cancer are highly treatable, especially when caught early. But the last frontier cases—those that can’t be treated with hormone or targeted therapies and don’t respond to chemotherapy—remain the deadliest and…

When Meghan Markle‘s closest friends threw her a baby shower in New York City ahead of Archie’s arrival, she was met with an unexpected reaction: immense disapproval. The celebration, held in Manhattan at The Mark Hotel, was an admittedly lavish…

Researchers from Rutgers Robert Wood Johnson Medical School’s Department of Neurology have traced a previously observed link between microscopic organisms in the digestive tract—collectively known as the gut microbiome—and multiple sclerosis (MS). Their study in genetically altered mice and people…

Dementia is on the rise in Germany. In the absence of treatment options, the focus is shifting to preventing dementia. In particular, a healthy lifestyle is considered beneficial for brain health. A study by the Faculty of Medicine now shows…

Some patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing program, pioneered by urologists, could help to close the gap for this underutilized resource, reports a study in Urology Practice®, an Official…

The cold and flu season of 2022 has begun with a vengeance. Viruses that have been unusually scarce over the past three years are reappearing at remarkably high levels, sparking a “tripledemic” of COVID-19, the flu and respiratory syncytial virus,…

Nearly 90% of beta-thalassemia patients were transfusion free for up to 8 years after treatment with the one-time gene therapy betibeglogene autotemcel (beti-cel), according to a report at the American Society of Hematology annual meeting. Surveyed at 3 years, patients also reported…

Britain’s cancer crisis laid bare: Nearly HALF of all cases aren’t diagnosed until they have spread – when survival rates are much lower, NHS data shows Almost half of cancers are being diagnosed in the later stages, a report revealed…

NEW ORLEANS – Patients with chronic immune thrombocytopenia (ITP) fared better on intravenous efgartigimod (Vyvgart) than a placebo, a new study found. Still, only 21.8% of subjects who received the biologic reached the primary endpoint of sustained platelet count response, an indication…